|Bid||43.41 x 800|
|Ask||43.80 x 900|
|Day's Range||42.88 - 44.22|
|52 Week Range||42.29 - 91.16|
|Beta (3Y Monthly)||1.48|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||81.64|
MOORESTOWN, N.J., May 22, 2019 -- Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ:TRHC), a healthcare technology company advancing the field of medication safety, today announced.
Capstone Performance Systems, a subsidiary of Tabula Rasa HealthCare, Inc. (TRHC) (TRHC), a leading provider of technology-enabled solutions to mitigate medication risk and improve health plan operations, has introduced new services and gained additional PACE (Program of All-inclusive Care for the Elderly) clients in the first quarter of 2019. Its expanding client roster includes two new PACE clients in Michigan, which recently began receiving Capstone risk adjustment and concurrent coding services.
Tabula Rasa Healthcare (TRHC) delivered earnings and revenue surprises of 66.67% and 2.90%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
On a per-share basis, the Moorestown, New Jersey-based company said it had a loss of 54 cents. Earnings, adjusted for stock option expense and amortization costs, came to 10 cents per share. The results ...
MOORESTOWN, N.J., May 08, 2019 -- Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ:TRHC), a healthcare technology company advancing the field of medication safety, today announced.
We at Insider Monkey have gone over 700 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio positions as of December 31st. In this article, we look at what those funds think of Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) based on […]
Tabula Rasa Healthcare (TRHC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Tabula Rasa HealthCare, Inc. (TRHC) (TRHC), a leading provider of technology-enabled solutions to mitigate medication risk and reduce medical costs, commends a new initiative from the U.S. Department of Health and Human Services (HHS) and Centers for Medicare & Medicaid Services (CMS) to introduce new payment models for primary care that will require payment for health and outcomes rather than fee-for-service. According to HHS Secretary Alex Azar, these models represent the biggest step ever taken toward building an American healthcare system that pays for value.
It hasn't been the best quarter for Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) shareholders, since the share price has fallen 16% in that time. But that doesn't change the reality that over twelve months the stock has don...
MOORESTOWN, N.J., April 24, 2019 -- Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC), a healthcare technology company advancing the field of medication safety, will release its first.
MOORESTOWN, N.J., April 22, 2019 -- Tabula Rasa HealthCare, Inc. (TRHC) (NASDAQ: TRHC), a leading provider of technology-enabled solutions to mitigate medication risk and.
“We are pleased to welcome Dr. Phillips and Ms. O’Brien to AMAG’s board,” said Gino Santini, chairman of the board of AMAG. “As AMAG continues to invest and focus on the development and commercialization of novel pharmaceutical products that address unmet medical needs, the deep experience and expertise that Dr. Phillips and Ms. O’Brien each bring will be invaluable to AMAG.
Tabula Rasa HealthCare, Inc. (TRHC) (TRHC), a healthcare technology company advancing the field of medication safety, today announced it has contracted with one of the largest health insurers in Arkansas. The partnership, through TRHC’s PrescribeWellness subsidiary, will improve quality and performance outcomes for eligible plan members who fit criteria by leveraging community pharmacists to improve medication adherence and address gaps in care.
Tabula Rasa HealthCare, Inc. (TRHC) (TRHC), a healthcare technology company advancing the field of medication safety, today announced that its newly-acquired precision dosing software company DoseMe completed the country’s first fully-integrated Precision Dosing Software solution for one of the nation’s leading health care providers with multiple locations in Florida. “We are pleased with the traction our recently-acquired DoseMeRx is garnering in the United States in helping patients with precision, parenteral pharmacotherapy,” said TRHC Chairman and CEO Calvin H. Knowlton, PhD.
MOORESTOWN, N.J., April 03, 2019 -- Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety and improving.
Some of the biggest gains can come from buying stocks that are undervalued by the market. The stocks covered below have struggled recently. But when you take a closer look, the setup for these stocks is actually very compelling right now. That's according to the Street's top performing analysts. They are predicting significant gains in the coming months. How can you find such stocks? Here we used TipRanks' Top Analysts Stocks tool. The tool allows you to select stocks with a 'Strong Buy' Street consensus, that have underperformed over the last three months. We also scanned for stocks that have serious upside potential from the current share price to the average analyst price target. Let's take a closer look at the 3 stocks that made the cut now: Health Insurance Innovations (HIIQ)Health insurance stock HIIQ (HIIQ– Research Report) is poised to rebound. On a one-month basis shares have crashed by 28%, but the result is that the stock now looks extremely inexpensive.Prompting the selffoff was the news that the House Energy and Commerce Committee launched an investigation into roughly a dozen STM (short-term medical) market participants including HIIQ. The investigation is requesting information on STM marketing practices, enrollment channels and data, commissions and complaints and various other matters.However analysts are staying firmly on side. Northland’s Michael Grondahl (Track Record & Ratings) calls the selloff ‘excessive’. He stamps a ‘top pick’ status on Health Insurance with an $85 price target, suggesting upside potential of over 200%! “HIIQ added another $100M to its stock buyback authorization and clearly sees the value we believe exists in the shares” writes the Top 100 analyst.Grondahl isn’t too concerned about the investigation. “We highlight HIIQ operations have recently been thoroughly scrutinized by the two plus years 42 state investigation which had no findings and no issues” he writes. “We believe if there was a serious issue it would have been found in the last two years.” Further any near-term legislation relating to limited duration plans has ‘no chance of passing the Senate.’ Indeed, no less than seven analysts have come out in support of HIIQ over the last three months:View HIIQ Price Target & Analyst Ratings Detail Conn’s (CONN)Home furnishings specialist Conn's Inc (CONN– Research Report) sells everything from computers to reclining sofas. It also offers a whole range of financing options with store credit cards and lease-to-own programs. The past several years proved tumultuous for CONN, as the company struggled to balance its credit and retail operations. However, under the direction of new CEO Norm Miller, and a fresh team of senior leaders, the CONN credit business is on a much more solid footing, supporting a return to expansion in retail. “We have been recommending CONN as a compelling, under-the-radar retail turnaround play for some time now. We remain decidedly impressed with the efforts of CEO Norm Miller and his team to not only fix, but substantially repair the company’s once ailing credit business” writes Oppenheimer’s Brian Nagel (Track Record & Ratings). While retail sales have been disappointing lately, Nagel views it as only a matter of time before CONN finds the right formula to better connect with consumers. He concludes: “The market appears to meaningfully underappreciate the nearer- and longer-term EPS power of a better-functioning CONN business model.”With a $40 price target, Nagel sees 75% upside potential for CONN. He is one of three analysts who have published recent ratings on the stock, all of which are a ‘Buy’:View CONN Price Target & Analyst Ratings Detail Tabula Rasa Healthcare (TRHC)Tabula Rasa (TRHC– Research Report) is a groundbreaking tech healthcare company. It’s cloud-based software empowers healthcare providers to create personalized programs for patients. The result: optimized medication regimens, improved patient outcomes and reduced medication risk. Meanwhile health care providers enjoy operational efficiencies and reduced medical costs. Five-star Cantor Fitzgerald analyst Steven Halper (Track Record & Ratings) has a Street-high $99 price target on TRHC. That suggests shares can explode 75% from current levels.“We believe the company should be able to successfully leverage its unique medication risk management technology in many different markets” he explains. “The company's revenue mix is improving with growth in its Enhanced Medication Therapy Management (EMTM) program and are likely to drive margins higher over time” the analyst continues. He has his eye on a recent White House report that alludes to support for TRHC solutions. The report discusses innovations with the potential to improve the lives of the elderly and the disabled. In particular, it mentions solutions that would allow clinicians to maintain proper dosing and reduce the simultaneous use of multiple medications.“We believe TRHC's MedWise software and RxCompanion platform would be suitable for these applications. Additionally, we believe government support for such medication risk mitigation tools represent a nice tailwind for TRHC” writes Halper. Overall, six out of seven analysts covering the stock rate TRHC a ‘Buy’, giving it a ‘Strong Buy’ consensus. Their average price target stands at $87.20…View TRHC Price Target & Analyst Ratings Detail Also check out: Spirit Airlines (SAVE)Ultra-low-cost carrier Spirit Airlines, Inc. (SAVE– Research Report) is the seventh largest commercial airline in the US. And the stock looks like a tremendous bargain right now. Shares are currently trading down 9% year-to-date. The company has been plagued by higher fuel prices, while conservative FY20 unit revenues also spooked investors. Indeed, top-rated Imperial Capital analyst Michael Derchin (Track Record & Ratings) has just slashed his price target from $92 to $83.However that’s only part of the story. First, even the $83 price target indicates substantial upside potential of 57%. Second, Derchin calls Spirit Airlines his top pick in the airline industry. He believes the stock represents an appealing opportunity, currently trading at just 7.0x FY20E EPS. Strong pricing power, strong ancillary revenue growth and key initiatives like revamping the website and frequent flier program should help drive growth says Derchin. That’s on top of ‘significantly improved’ operational efficiency resulting in top-tier margins and a potential credit card agreement with Bank of America.Encouragingly, the Street shares this upbeat outlook. Out of the 9 analysts polled by TipRanks over the last three months, all 9 rate the stock a buy. With a $77 average analyst price target, these analysts are forecasting 46% upside potential. View SAVE Price Target & Analyst Ratings Detail Enjoy the Research Report on the Stocks in this Article:Conn's Inc (CONN) Research ReportHealth Insurance Innovations Inc (HIIQ) Research ReportSpirit Airlines Inc (SAVE) Research ReportTabula Rasa HealthCare Inc (TRHC) Research ReportFind fresh investing inspiration with the TipRanks Analysts’ Top Stocks tool. Using this recently revamped tool you can find the latest stock picks from analysts that consistently outperform. Discover ‘Strong Buy’ stocks in the sector that interests you. Go to Analysts’ Top Stocks now.
MOORESTOWN, N.J., March 21, 2019 -- Tabula Rasa HealthCare, Inc. (TRHC) (NASDAQ: TRHC) President Orsula V. Knowlton, PharmD, MBA, will be named a Fellow of the American.